Patient-reported outcomes study shows improvements in quality of life among patients after 1 year of treatment with TYSABRI
Friday, April 16, 2010 - 02:42
in Health & Medicine
TORONTO -- April 16, 2010 -- Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced results from a one-year, longitudinal health outcomes study (n=324) in which patients...